Target eye pressure is the range of eye pressures that ensures that there is no continued optic nerve damage. This is the pressure level at which the optic nerve is least likely to suffer further damage, for that particular individual. This target helps guide treatment decisions and long-term monitoring in glaucoma care.
Here is what patients must understand about Target Eye Pressure in Glaucoma, Dr Shibal Bhartiya, fellowship trained glaucoma specialist, explains. Glaucoma treatment focuses on protecting the optic nerve and preventing vision loss over time. The most important modifiable factor in glaucoma management is intraocular pressure (IOP), the pressure inside the eye.
Rather than aiming for a single “normal” number, glaucoma specialists set something called a target eye pressure for each patient. This is the pressure level at which the optic nerve is least likely to suffer further damage. Target pressure, thus, is not one fixed number. It is individualised, evidence-based, and reviewed at every follow-up. It is the foundation on which all glaucoma treatment decisions rest.
Target eye pressure is the level at which eye pressure should remain low enough to reduce the risk of further damage to the optic nerve.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
What is target eye pressure?
Target eye pressure is the individualised pressure goal set for each glaucoma patient.
It represents the pressure level that doctors believe will slow or stop further optic nerve damage.
The target is not the same for every patient. Instead, it depends on several factors including:
• severity of glaucoma
• current optic nerve damage
• visual field changes
• baseline eye pressure
• patient age and life expectancy
• risk of disease progression
Because glaucoma behaves differently in different individuals, target pressure must be personalised.
Why target pressure is important
Glaucoma damage occurs when the optic nerve cannot tolerate the pressure inside the eye.
Some people develop glaucoma at relatively low pressures, while others tolerate higher pressures without damage.
Target pressure therefore helps doctors answer an important question:
How low does the eye pressure need to be to protect this patient’s vision over time?
Once a target pressure is established, treatment is designed to reach and maintain that level.
Target pressure is not the same as “normal pressure”
Many patients assume that eye pressure below 21 mmHg is safe.
However, glaucoma can occur even when pressure falls within the traditionally “normal” range.
For some patients, the optic nerve may only remain stable if pressure is much lower than average.
This is why glaucoma treatment focuses on target pressure rather than normal pressure.
How doctors determine target eye pressure
Glaucoma specialists do not guess at a target. They calculate it from clinical data gathered at your first detailed assessment.
The starting point is your baseline IOP — the pressure in your eye before any treatment begins. Most specialists aim for a reduction of at least 20 to 30 percent from baseline. For a patient with a baseline pressure of 26 mmHg, that means a target somewhere between 18 and 21 mmHg. For a patient with advanced damage, the target may need to be below 15 mmHg or even lower.
Several other factors shape the final number:
Severity of optic nerve damage. Advanced glaucoma requires lower target pressures. The more damage already present, the less room there is for further loss.
Rate of disease progression. If glaucoma is moving quickly, the target pressure is set lower and reviewed more frequently.
Visual field changes. Worsening peripheral vision tells the doctor that the current pressure is not low enough, even if it appears “controlled” on paper.
Age and life expectancy. A 40-year-old with mild glaucoma needs pressure controlled for the next 40 or 50 years. The target for that patient will be set more aggressively than for someone older with slower-moving disease.
Normal tension glaucoma. Some patients develop glaucoma at pressures below 21 mmHg. In these cases, the target may need to be set well below the statistical “normal” range — sometimes as low as 12 mmHg.
At the end of this assessment, the doctor names a specific pressure target in mmHg. Treatment is then designed to reach and hold that number or range of IOP.
How target pressure guides treatment
Once a target pressure is defined, treatment aims to achieve that goal.
Possible treatments include:
• glaucoma eye drops
• laser procedures
• minimally invasive glaucoma surgery (MIGS)
• traditional glaucoma surgery
Doctors monitor whether pressure remains consistently below the target level during follow-up visits.
If pressure rises above the target or optic nerve damage progresses, treatment may need to be adjusted or intensified.
Target pressure may change over time
Target eye pressure is not permanent.
As glaucoma evolves, doctors may need to revise the target pressure.
This can happen if:
• optic nerve damage progresses
• visual fields worsen
• pressure fluctuations increase
• the disease becomes more aggressive
In such cases, the target pressure may need to be lowered further to protect vision.
Dr Bhartiya has published peer-reviewed research on Target IOP in glaucoma practice, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. Her 2014 paper, Target Intraocular Pressure: Approaches and Options, examines how glaucoma specialists should set, communicate, and revise pressure targets, balancing clinical evidence, patient preferences, and long-term vision outcomes. It is cited by glaucoma surgeons internationally and is freely available on PubMed.
The role of long-term monitoring
Glaucoma is a chronic disease that requires lifelong monitoring.
Even when target pressure is achieved, doctors must continue to evaluate:
• optic nerve appearance
• visual field tests
• retinal nerve fibre layer imaging
• pressure fluctuations
These tests help determine whether the target pressure is actually protecting the optic nerve.
Why glaucoma care focuses on long-term risk
One of the most important principles in glaucoma care is thinking long-term.
The goal is not simply to lower pressure today, but to protect vision for the patient’s lifetime.
Target eye pressure therefore represents a risk-management strategy, balancing treatment intensity with long-term safety.
When patients seek a second opinion
Some patients seek a second opinion when:
• glaucoma continues to progress despite treatment
• surgery is being recommended
• multiple medications are required
• target pressure goals are unclear
A second opinion may help clarify whether the current target pressure is appropriate and whether alternative treatments should be considered.
Frequently asked questions about target eye pressure
What is a normal target eye pressure in glaucoma?
There is no single “normal” target. Most specialists aim for a reduction of 20 to 30 percent from your baseline pressure before treatment. For many patients this means a target between 15 and 18 mmHg. For patients with advanced glaucoma or normal tension glaucoma, the target may be set lower.
How is target eye pressure calculated?
Your doctor uses your baseline IOP, the degree of optic nerve damage, your visual field results, your age, and the rate at which your glaucoma is progressing. These factors together determine the pressure level at which your optic nerve is most likely to remain stable over your lifetime.
What happens if my eye pressure stays above the target?
If IOP consistently exceeds your target, the risk of further optic nerve damage rises. Your doctor will review your treatment: this may mean adding a second eye drop, changing medications, performing laser treatment, or recommending surgery.
Can target eye pressure change over time?
Yes. Target pressure is reviewed at every follow-up. If your optic nerve shows new damage, if visual fields worsen, or if your glaucoma progresses despite reaching the original target, the target will be revised downward.
Is eye pressure below 21 mmHg always safe?
No. The figure of 21 mmHg is a statistical average, not a safety threshold. Some patients develop glaucoma at pressures of 14 or 15 mmHg. For these patients, “normal” pressure is not low enough to protect the optic nerve.
How often should I have my eye pressure checked in glaucoma?
Most glaucoma patients need pressure checks every three to six months. Patients who are newly diagnosed, changing treatment, or progressing quickly may need checks more frequently. Pressure is only one part of monitoring, OCT imaging and visual field testing are equally important.
What to expect at your first target IOP consultation
If you are seeing a glaucoma specialist for the first time, here is what the target pressure conversation looks like in practice.
Your doctor will review your full clinical picture: baseline pressures from previous records, OCT scans of the optic nerve and retinal nerve fibre layer, visual field test results, your age, and any family history of glaucoma.
Based on this, the doctor will name a target — for example, “We need your pressure below 16 mmHg consistently.” That number becomes the benchmark for every decision going forward.
You should feel free to ask: What is my target pressure? Why did you choose that number? What happens if we cannot reach it with drops alone? A good glaucoma specialist will answer all three without hesitation.
If your target pressure has never been discussed with you, or if your glaucoma continues to progress despite reaching the stated target, that is a reasonable reason to seek a second opinion.
Key takeaways
• Target eye pressure is the pressure level doctors aim for to protect the optic nerve
• The target is individualised for each patient
• Glaucoma treatment focuses on reaching and maintaining this level
• Target pressure may change as the disease evolves
• Lifelong monitoring is necessary to ensure the optic nerve remains stable
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma
